Key facts
- This page summarizes Yuma Regional Medical Center's Form 3 filing for PALISADE BIO, INC. (PALI).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 26 Aug 2021, 21:04.
Yuma Regional Medical Center - 19 Aug 2021 Form 3 Insider Report for PALISADE BIO, INC. (PALI)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- PALI
- Reported as of
- 19 Aug 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ David Willie, Chief Financial Officer
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Yuma Regional Medical Center filed Form 3 for PALISADE BIO, INC. (PALI) on 26 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PALI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,814,375
- Date
- 19 Aug 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PALI
holding
Derivative
Warrant to Purchase Common Stock (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 19 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 377,474
- Exercise price
- $3.45
PALI
holding
Derivative
Warrant to Purchase Common Stock (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 19 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,785
- Exercise price
- $41.20
PALI
holding
Derivative
Warrant to Purchase Common Stock (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 19 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,595
- Exercise price
- $41.20
PALI
holding
Derivative
Warrant to Purchase Common Stock (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 19 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,223
- Exercise price
- $26.85
* marks a reported price that did not pass the local price check.